The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Hyperimmune IV Immunoglobulin Treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934
Research works printed but not linked: 29
- Cheng, 2012, Two years after pandemic influenza A/2009/H1N1: what have we learned?, Clin Microbiol Rev, 25, 223, 10.1128/CMR.05012-11 · DOI · Paper page
- To, 2010, Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection, Postgrad Med J, 86, 515, 10.1136/pgmj.2009.096206 · DOI
- Hancock, 2009, Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus, N Engl J Med, 361, 1945, 10.1056/NEJMoa0906453 · DOI · Paper page
- Louie, 2009, Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California, JAMA, 302, 1896, 10.1001/jama.2009.1583 · DOI · Paper page
- Chan, 2011, The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation, Clin Vaccine Immunol, 18, 305, 10.1128/CVI.00363-10 · doi:10.1128/cvi.00363-10
- Gordon, 2010, Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency, Clin Infect Dis, 50, 672, 10.1086/650462 · DOI
- Zhou, 2012, A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection, J Infect Dis, 206, 495, 10.1093/infdis/jis378 · doi:10.1093/infdis/jis378
- Li, 2010, The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment, Chest, 137, 759, 10.1378/chest.09-3072 · DOI
- Davies, 2009, Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome, JAMA, 302, 1888, 10.1001/jama.2009.1535 · DOI · Paper page
- Chan, 2010, Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1), Hong Kong Med J, 16, 447
- Luke, 2006, Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?, Ann Intern Med, 145, 599, 10.7326/0003-4819-145-8-200610170-00139 · DOI · Paper page
- Zhou, 2007, Treatment with convalescent plasma for influenza A (H5N1) infection, N Engl J Med, 357, 1450, 10.1056/NEJMc070359 · DOI · Paper page
- Hung, 2011, Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection, Clin Infect Dis, 52, 447, 10.1093/cid/ciq106 · DOI · Paper page
- Wong, 2010, Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection, Transfusion, 50, 1967, 10.1111/j.1537-2995.2010.02651.x · doi:10.1111/j.1537-2995.2010.02651.x
- Hung, 2010, Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009, Clin Infect Dis, 51, 274, 10.1086/653940 · doi:10.1086/653940
- To, 2010, Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection, Clin Infect Dis, 50, 850, 10.1086/650581 · DOI · Paper page
- Arankalle, 2010, Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients, PLoS One, 5, 10.1371/journal.pone.0013099 · DOI
- Steensberg, 2003, IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans, Am J Physiol Endocrinol Metab, 285, E433, 10.1152/ajpendo.00074.2003 · DOI · Paper page
- Monsalvo, 2011, Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes, Nat Med, 17, 195, 10.1038/nm.2262 · DOI · Paper page
- To, 2012, High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza, Clin Vaccine Immunol, 19, 1012, 10.1128/CVI.00081-12 · DOI
- Jefferson, 2000, Neuraminidase inhibitors for preventing and treating influenza in healthy adults, Cochrane Database Syst Rev
- Inoue, 2010, Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours, Emerg Infect Dis, 16, 1633, 10.3201/eid1610.100688 · DOI
- Macmillan, 2010, Intravenous immunoglobulin G selectively inhibits IL-1α-induced neutrophil-endothelial cell adhesion, Autoimmunity, 43, 619, 10.3109/08916931003599062 · DOI
- Tse, 2011, Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection, PLoS ONE, 6, e22534, 10.1371/journal.pone.0022534 · DOI
- Chan, 2010, Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice, PLoS ONE, 5, e13757, 10.1371/journal.pone.0013757 · DOI
- Nave, 2011, Obesity-related immunodeficiency in patients with pandemic influenza H1N1, Lancet Infect Dis, 11, 14, 10.1016/S1473-3099(10)70304-2 · DOI
- Fowlkes, 2011, Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009, Clin Infect Dis, 52, S60, 10.1093/cid/ciq022 · DOI
- Shoemaker, 2012, Integrated network analysis reveals a novel role for the cell cycle in 2009 pandemic influenza virus-induced inflammation in macaque lungs, BMC Syst Biol, 6, 117, 10.1186/1752-0509-6-117 · DOI
- Wu, 2010, Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic, Proc Natl Acad Sci U S A, 107, 3269, 10.1073/pnas.0911596107 · DOI
Cited by
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094
Convalescent plasma as a potential therapy for COVID-19
Chen, L., Xiong, J., Bao, L., & Shi, Y. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30141-9 · Cited by 1,038
Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K. D., Convalescent Plasma Study Group, Nguyen-Van-Tam, J. S., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 983
Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45538 · Cited by 960
Metadata
- Authors
- Hung, I. F. N., To, K. K. W., Lee, C.-K., Lee, K.-L., Yan, W.-W., Chan, K., Chan, W.-M., Ngai, C.-W., Law, K.-I., Chow, F.-L., Liu, R., Lai, K.-Y., Lau, C. C. Y., Liu, S.-H., Chan, K.-H., Lin, C.-K., & Yuen, K.-Y.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 144
- Issue
- 2
- Pages
- 464-473
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W1964402677
- Cited by
- 286
- References
- 1
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperimmune IV Immunoglobulin Treatment. https://app.cochat.ai/papers/10.1378/chest.12-2907
- The paper
- Hung, I. F. N., To, K. K. W., Lee, C.-K., Lee, K.-L., Yan, W.-W., Chan, K., Chan, W.-M., Ngai, C.-W., Law, K.-I., Chow, F.-L., Liu, R., Lai, K.-Y., Lau, C. C. Y., Liu, S.-H., Chan, K.-H., Lin, C.-K., & Yuen, K.-Y. (2013). Hyperimmune IV Immunoglobulin Treatment. Chest. https://doi.org/10.1378/chest.12-2907
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.